afutuzumab (99)							

Structure	

Heavy chain / Chaone lourde / Cadena pesada

QVQLVQSGAE	VKKPGSSVKV	SCKASGYAFS	YSWINWVRQA	PGQGLEWMGR	50

IFPGDGDTDY	NGKFKGRVTI	TADKSTSTAY	MELSSLRSED	TAVYYCARNV	100

FDGYWLVYWG	QGTLVTVSSA	STKGPSVFPL	APSSKSTSGG	TAALGCLVKD	150

YFPEPVTVSW	NSGALTSGVH	TFPAVLQSSG	LYSLSSVVTV	PSSSLGTQTY	200

ICNVNHKPSN	TKVDKKVEPK	SCDKTHTCPP	CPAPELLGGP	SVFLFPPKPK	250

DTLMISRTPE	VTCVVVDVSH	EDPEVKFNWY	VDGVEVHNAK	TKPREEQYNS	300

TYRVVSVLTV	LHQDWLNGKE	YKCKVSNKAL	PAPIEKTISK	AKGQPREPQV	350

YTLPPSRDEL	TKNQVSLTCL	VKGFYPSDIA	VEWESNGQPE	NNYKTTPPVL	400

DSDGSFFLYS	KLTVDKSRWQ	QGNVFSCSVM	HEALHNHYTQ	KSLSLSPG	448

Light chain / Chaone lygire / Cadena ligera

DIVMTQTPLS	LPVTPGEPAS	ISCRSSKSLL	HSNGITYLYW	YLQKPGQSPQ	50?

LLIYQMSNLV	SGVPDRFSGS	GSGTDFTLKI	SRVEAEDVGV	YYCAQNLELP	100?

YTFGGGTKVE	IKRTVAAPSV	FIFPPSDEQL	KSGTASVVCL	LNNFYPREAK	150?

VQWKVDNALQ	SGNSQESVTE	QDSKDSTYSL	SSTLTLSKAD	YEKHKVYACE	200?

VTHQGLSSPV	TKSFNRGEC



219?

Disulfide bridges location / Position des ponts disulfure / Posiciones
de los puentes disulfuro

22-96	22??-96??	23?-93?	23???-93???	139?-199?	139???-199???	146-202
146??-202??

219?-222	219???-222??	228-228??	231-231??	263-323	263??-323??	369-427
369??-427??

Glycosylation sites / Sites de glycosylation / Posiciones de
glicosilaciun

Ser-53	Ser-61	Asn-157	Thr-159	Asn-167	Thr-169



Molecular formula	C6512H10060N1712O2020S44

Description

immunoglobulin G1, anti-[Homo sapiens CD20 (membrane-spanning 4-domains
subfamily A member 1, MS4A1, B lymphocyte surface antigen B1, Leu-16,
Bp35)], humanized monoclonal antibody, GA101; gamma1 heavy chain (1-448)
[humanized VH (Homo sapiens FR/Mus musculus CDR, Homo sapiens IGHJ4*01)
[8.8.12] (1-119) -Homo sapiens IGHG1*01 (120-448)], (222-219?)-disulfide
with kappa light chain (1?-219?) [humanized 

V-KAPPA (Homo sapiens FR/Mus musculus CDR, Homo sapiens IGKJ4*01)
[11.3.9]

(1?-112?) -Homo sapiens IGKC*01 (113?-219?)];
(228-228??:231-231??)-bisdisulfide dimer

	

WHO 

International Nonproprietary Names Programme	

9043

1/1

		

